ID   ASF-4-1
AC   CVCL_2854
SY   ASF 4-1
DR   BioSample; SAMN03472790
DR   JCRB; IFO50418
DR   Wikidata; Q54750697
RX   PubMed=27073551;
CC   Population: Japanese.
CC   Characteristics: The ASF-4 series of cell lines were established from the skin of the same donor at different ages.
CC   Doubling time: 2-2.5 days (Note=Lot 07222002) (JCRB=IFO50418).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=IFO50418
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D5S818: 9,10
ST   D7S820: 10,11
ST   TH01: 8,9
ST   TPOX: 11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2855 ! ASF-4-2
OI   CVCL_8497 ! ASF-4-3L
OI   CVCL_8498 ! ASF-4-4L1
OI   CVCL_8499 ! ASF-4-4L2
OI   CVCL_8500 ! ASF-4-4R2
OI   CVCL_JG42 ! ASF-4-5L1
OI   CVCL_JG43 ! ASF-4-5L2
OI   CVCL_JG44 ! ASF-4-5R1
SX   Male
AG   36Y2M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
RX   PubMed=27073551; DOI=10.3892/ol.2016.4289; PMCID=PMC4812595;
RA   Fujiwara, Masaya
RA   Kanayama, Kazuki
RA   Hirokawa, Yoshifumi S.
RA   Shiraishi, Taizo
RT   "ASF-4-1 fibroblast-rich culture increases chemoresistance and mTOR
RT   expression of pancreatic cancer BxPC-3 cells at the invasive front in
RT   vitro, and promotes tumor growth and invasion in vivo.";
RL   Oncol. Lett. 11:2773-2779(2016).
//